Subsidies for Ozempic will be restricted in Novo Nordisk A/S’s home country of Denmark due to rising public spending on the blockbuster diabetes medicine, which is increasingly being used as a weight-loss treatment.
BBVA’s Deal Appetite Signals a Bigger Shakeup at European BanksUK House Prices Fall Again After Mortgage Rates Creep HigherIMF Approves $120 Million of Emergency Financing Support to MaliEurope’s Biggest Smart City Rises in GreeceHuge FX Gains Are Japan’s Benefit From Intervention, Setser SaysRate-Hike Risk Creeps Up on Emerging Markets as Bond Bets FizzleSpinneys’ $375 Million Dubai IPO Draws Orders Worth $19 BillionActively Managed Funds Hemorrhage Client Cash in ESG UpheavalMilei Wins Key...
4% in FebruaryChina State Firm to Sell 20 Shanghai Office Towers in DownturnChina Home Sales Keep Falling as Top Officials Pledge SupportJeremy Hunt Warns Against UK FCA’s ‘Name and Shame’ PlansBBVA’s Deal Appetite Signals a Bigger Shakeup at European BanksUK House Prices Fall Again After Mortgage Rates Creep HigherGodrej Group Splits Conglomerate to Maintain Family ‘Harmony’Musk’s Starlink Inches Closer to Yemen License, Official SaysGSK Expects Higher Profits Boosted By Vaccines, Asthma...
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
US Senate committee investigates pricing of Novo's Ozempic and WegovyExplore stories from Atlantic Canada.
Read more »
US Senate committee investigates pricing of Novo's Ozempic and WegovyExplore stories from Atlantic Canada.
Read more »
U.S. Senate committee investigates pricing of Novo’s Ozempic and WegovySenator Bernie Sanders sent a letter to Novo’s CEO seeking more information on U.S. prices for the two drugs, which are higher than the prices in other countries
Read more »
TikTok’s Crackdown on Ozempic Influencers Threatens Weight-Loss Drug Hype MachineCreators say the rules are unfair and harmful to their businesses
Read more »
Molson Coors Says ‘Volatile Times,’ Not Ozempic, Dim Its Beer OutlookMolson Coors Brewing Co.’s more cautious outlook for beer consumption isn’t coming from the new class of weight-loss drugs, which some have speculated would dent the alcohol industry, its chief executive officer said.
Read more »
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competitionWASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest...
Read more »